Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 062298

Expand all

ERY-TAB (ERYTHROMYCIN)
250MG
Marketing Status: Prescription

Active Ingredient: ERYTHROMYCIN
Proprietary Name: ERY-TAB
Dosage Form; Route of Administration: TABLET, DELAYED RELEASE; ORAL
Strength: 250MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A062298
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ERY-TAB (ERYTHROMYCIN)
333MG
Marketing Status: Prescription

Active Ingredient: ERYTHROMYCIN
Proprietary Name: ERY-TAB
Dosage Form; Route of Administration: TABLET, DELAYED RELEASE; ORAL
Strength: 333MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A062298
Product Number: 003
Approval Date: Mar 29, 1982
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ERY-TAB (ERYTHROMYCIN)
500MG
Marketing Status: Prescription

Active Ingredient: ERYTHROMYCIN
Proprietary Name: ERY-TAB
Dosage Form; Route of Administration: TABLET, DELAYED RELEASE; ORAL
Strength: 500MG
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB
Application Number: A062298
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information